Dysfunctional immunoregulation in human liver allograft rejection associated with compromised galectin-1/CD7 pathway function.
Dysfunctional immunoregulation in human liver allograft rejection associated with compromised galectin-1/CD7 pathway function.
复制标题
与半乳糖凝集素 1/CD7 通路功能受损相关的人肝同种异体移植排斥反应中功能失调的免疫调节
DOI:
10.1038/s41419-017-0220-3
复制
发表时间:
2018-02-20
影响因子:
9
通讯作者:
Wu Y
中科院分区:
文献类型:
--
作者:
Wei S;Cao D;Liu Z;Li J;Wu H;Gong J;Liu Y;Wu Y
Regulatory T cells in rejected allograft patients display an inability to control responder T cells. Galectin-1 (Gal1) inhibits responder T cells through binding CD7. We investigated whether the dysfunctional immunoregulation in liver allograft rejection patients results from reduced regulatory T-cell Gal1 expression and/or responder T-cell CD7 expression. Circulating regulatory T cells and responder T cells were profiled from 31 acute rejection transplant patients, 85 transplant patients in remission, and 40 healthy controls. CD7+ and CD7− responder T cells were co-cultured with regulatory T cells to assess regulatory T-cell suppressor function. Gal1-small interfering RNA was used to silence regulatory T-cell Gal1. The CD7+ cell percentage was inversely correlated with AST, ALT, and GGT levels. The proportions of CD7+ responder T cells and Gal1+ regulatory T cells were higher in healthy controls than in transplant patients in remission and lowest in acute rejection transplant patients. Notably, CD7+ responder T-cell susceptibility to Gal1+ regulatory T-cell control was ranked in the same manner. Silencing Gal1 expression in regulatory T cells reduced their ability to suppress CD7+ (but not CD7−) responder T cells. Additionally, the proportions of CD43+ and CD45+ responder T cells were higher in healthy controls than in acute rejection transplant patients. CD43 co-expression (but not CD45 co-expression) on CD7+ responder T cells promoted their apoptosis in a Gal1-dependent manner. In sum, dysfunctional immunoregulation in liver allograft rejection patients can be partly attributed to reduced regulatory T-cell Gal1 expression and reduced responder T-cell CD7 expression. Responder T-cell CD43 downregulation in acute rejection patients may further contribute to reduced responder T-cell responsiveness to regulatory T-cell control.
登录
查看更多内容
DOI:
10.1111/ajt.12509
发表时间:
2014-01
期刊:
American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons
影响因子:
--
作者:
Lee K;Nguyen V;Lee KM;Kang SM;Tang Q
通讯作者:
Tang Q
DOI:
10.1111/ajt.13197
发表时间:
2015-01-01
期刊:
American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons
影响因子:
--
作者:
Kim, W R;Lake, J R;Kasiske, B L
通讯作者:
Kasiske, B L
DOI:
10.4049/jimmunol.0803833
发表时间:
2009-05-15
期刊:
Journal of immunology (Baltimore, Md. : 1950)
影响因子:
--
作者:
Pericolini E;Gabrielli E;Cenci E;De Jesus M;Bistoni F;Casadevall A;Vecchiarelli A
通讯作者:
Vecchiarelli A
影响因子:
20.3
作者:
Garin, Marina I.;Chu, Chung-Ching;Lechler, Robert I.
通讯作者:
Lechler, Robert I.
影响因子:
5.4
作者:
Moreau, Aurelie;Noble, Alistair;Lombardi, Giovanna
通讯作者:
Lombardi, Giovanna